BloodCenter of Wisconsin’s Diagnostic Laboratories earlier this week announced the availability of genetic deletion/duplication analysis. Using array Comparative Genomic Hybridization (aCGH), the test provides timely detection of deletions and/or duplications, which may escape detection with standard DNA sequencing tests.
BloodCenter’s test allows for the detection of deletions and duplications within a given gene, whether within a single exon, encompassing one or more exons, or the entire gene.
“BloodCenter of Wisconsin is well known for its expertise in non-malignant blood disorders,” said Rupa Udani, director of BloodCenter’s molecular diagnostics laboratory. “We now are able to determine the underlying genetic cause of hematologic disease for patients, which was previously not possible using DNA sequencing alone.”
BloodCenter’s comprehensive testing approach provides clinical consultation with follow-up testing recommendations for patients and at-risk family members, as well as genetic consultation to physicians to ensure appropriate testing algorithm.
Since BloodCenter has the ability to interpret aCGH test results with sequencing results, it can provide physicians with a comprehensive genetic analysis to enhance patient care.
BloodCenter’s Diagnostic Laboratories help physicians provide clinical care to patients worldwide. In addition, the laboratories collaborate with other institutions and industry partners to bring new diagnostic testing and treatment options to patient care.
BloodCenter of Wisconsin is part of Versiti, which also includes Heartland Blood Centers of Aurora, Ill.; Indiana Blood Center; and Michigan Blood.
